. Epinephrine infusion increases adipose interleukin-6 gene expression and systemic levels in humans.
PLASMA EPINEPHRINE LEVELS increase markedly in response to physical activity (6) , and exercise is known to affect several metabolic genes at both the mRNA and plasma levels (21) . However, it is not possible to discriminate whether the exercise-induced metabolic effects are mediated via epinephrine or muscle contraction-induced factors. Recent research suggests that the cytokine IL-6, which is markedly enhanced during exercise, may play important metabolic roles (29) . The exercise-induced increase in systemic levels of IL-6 is thought to originate from contracting skeletal muscles (20, 24) . However, adipose tissue may also contribute as IL-6 mRNA expression in subcutaneous fat is increased by exercise (9, 10) .
IL-6 secretion increases when human adipocyte cultures are incubated with epinephrine. Moreover, stimulation of ␤-adrenergic receptors via isoproterenol increases both IL-6 mRNA levels and IL-6 secretion in vitro in human breast adipocytes (18) . In rat fibroblasts, epinephrine stimulation increases IL-6 gene expression levels (1, 7) through any of the three epinephrine receptor subtypes, ␣ 1A , ␣ 1B , and ␣ 1D , as shown by microarray analysis (7) . In humans, epinephrine infusion induces only a modest increase in plasma IL-6 compared with exercise (23) . However, muscle-derived IL-6 is not likely to be induced by epinephrine: in a two-legged human model, IL-6 was released from the working limb, but not from a resting limb, although they were exposed to the same systemic catecholamine levels (24) . Thus it is possible that epinephrine stimulates the release of IL-6 from adipose tissue.
Because recombinant human IL-6 infusion in humans increases muscle IL-6 mRNA expression, muscle-derived IL-6 may act in an autocrine manner; this effect is less clear for adipose tissue (10) . In mouse 3T3-L1 adipocytes (3) and in other cell culture types (4, 12, 27) , an autocrine regulation does exist, and expression of IL-6, the IL-6 receptor (IL-6R), and the signal-transducing gp130 receptor is demonstrated in mature human adipose breast tissue (18) . Thus it may be that this autocrine feedback loop is substantiated by increasing the production of the IL-6R in response to epinephrine infusion.
Therefore, the purpose of this study was to test the hypothesis that epinephrine is involved in the regulation of IL-6 gene expression levels in adipose tissue and circulating IL-6 levels in healthy men. In addition, we investigated IL-6R mRNA expression in adipose tissue.
MATERIALS AND METHODS

Subjects.
Ten subjects participated in the study [means Ϯ SE: age 27 Ϯ 1 yr, height 184 Ϯ 2 cm, weight 83 Ϯ 3 kg, body mass index (BMI) 24.4 Ϯ 0.7 kg/m 2 ]. The study was approved by the Ethical Committee of the Copenhagen and Frederiksberg Communities, Denmark, and was performed according to the Declaration of Helsinki. Subjects were informed about possible risks and discomfort before giving their informed, written consent to participate. Subjects had no medical history, and physical examination revealed no abnormalities. The subjects did not use any medication and did not have any febrile illness in the fortnight preceding the study. Furthermore, subjects abstained from heavy exercise 2 days in advance of the experiments. Six of the subjects served as their own controls.
On the experimental day, subjects arrived at 0800 after an overnight fast. The femoral vein of one limb was cannulated and used for the infusion. Subjects (n ϭ 8) were infused for 3 h with epinephrine diluted in saline in a total volume of 80 ml. For the first 1.5 h, epinephrine was infused at a rate of 24 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 , and, for the final 1.5 h, the rate was increased to 42 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 to mimic epinephrine levels seen during intense exercise. Control persons (n ϭ 8) were infused with saline for 3 h. The infusions were performed in a randomized order. Biopsies were obtained from abdominal subcutaneous adipose tissue by using the percutaneous needle biopsy technique with suction preceded by a subcutaneous injection of lidocaine. Biopsies were obtained before infusion, after 1.5 h of infusion, at the cessation of infusion, and 1.5, 3, and 5 h postinfusion. Blood samples were collected before infusion, 0.5 and 1.5 h during the infusion, at the cessation of infusion, and 1.5, 3, and 5 h postinfusion.
Subjects were permitted to consume only water during the experiment.
Adipose tissue samples were analyzed for IL-6 and the IL-6R mRNA levels by real-time PCR with the use of an ABI PRISM 7900 sequence detector (PE Biosystems). IL-6 Taqman probe and primers were as described (10) . IL-6R primers and Taqman probe were designed by using the computer program Primer Express 2.0. To ensure the specificity of the primers and probe, a gel was run, in which a single band of the correct size of 126 bp was obtained as follows: IL-6R: forward primer, 5Ј-AAGACCCCCACTCCTGGAACT-3Ј; reverse primer, 5Ј-CGTGGATGACACAGTGATGCT-3Ј; Taqman probe, 5Ј-ACCATCCATGTTGTGAATGTCTTTGACCG-3Ј. The gene expression levels were normalized to the housekeeping gene 18S (obtained from Applied Biosystems). All reactions were run under singleplex conditions. Data were quantitated and normalized using the standard curve method.
Blood samples for measurement of cytokines were drawn into glass tubes containing EDTA. The tubes were spun immediately at 3,500 g for 15 min at 4°C. The plasma was stored at Ϫ80°C until analyses were performed. A high-sensitivity ELISA kit from R&D System (Minneapolis, MN) was used to measure IL-6 in plasma. The IL-6 kit does not distinguish between soluble and receptor-bound IL-6 and, therefore, gives a measure of the total IL-6 content in the sample.
Free fatty acids (FFA) and glucose levels were determined by COBAS (Fara, Roche) analysis on plasma. Plasma insulin was measured using ELISA kits (no. K6219) from DAKO, UK.
For measurement of plasma epinephrine, blood was drawn into ice-cold glass tubes containing glutathione (1.3 mg/ml blood) and EGTA (1.5 mg/ml blood), pH 6 -7, and spun immediately. Plasma was stored at Ϫ80°C until analysis by high-performance liquid chromatography (Hewlett-Packard, Waldbronm, Germany) with electrochemical detection.
Statistics. Data on plasma IL-6 and IL-6 mRNA and plasma epinephrine were log transformed, and data on IL-6R mRNA were square root transformed to reach a normal distribution. Data are presented as means Ϯ SE or as geometric means Ϯ SE or as 95% confidence interval with respect to transformed data. Data on FFA plasma levels were normally distributed; however, insulin and glucose plasma data could not be normally distributed, and thus nonparametric statistics were used.
For analysis of data, a two-way repeated-measures (RM)-ANOVA was used to detect changes over time or between groups. StudentNewman-Keul's t-test for post hoc analysis was used to detect changes over time from resting values or differences between groups. According to the nonparametric statistics, a RM-ANOVA on ranks was used. P values Ͻ0.05 were considered significant. Statistical calculations were performed by using Sigma Stat 3.0 (SPSS, Chicago, IL).
RESULTS
Adipose tissue IL-6 mRNA levels increased ϳ26-fold (95% confidence interval; 9 -166 fold) in response to epinephrine infusion, peaking at the cessation of the 3-h infusion (2-way RM-ANOVA; P ϭ 0.028; Fig. 1 ). There were no changes in adipose tissue IL-6 mRNA in response to saline infusion.
Plasma IL-6 levels increased to 5 pg/ml at 3 h of epinephrine infusion (2-way RM-ANOVA; P Ͻ 0.001) and then decreased after the end of the infusion. IL-6 plasma levels were increased in both groups at 1.5, 3, and 5 h after the end of the infusion period owing to circadian rhythms (see Table 1 ).
As expected, epinephrine levels increased in the epinephrine infusion trial only (2-way RM-ANOVA; P Ͻ 0.001), peaking at ϳ2.1 nmol/l at the end of the 3-h infusion and returning to baseline by 1.5 h after cessation of the epinephrine infusion (see Table 1 ).
In contrast to effects on IL-6, epinephrine infusion did not affect adipose tissue mRNA levels of the IL-6R (see Table 2 ).
In the epinephrine-infused group, insulin plasma levels increased (RM-ANOVA on ranks; P Ͻ 0.001) during the infusion period and decreased 3 and 5 h after the cessation of infusion. Insulin levels decreased in the control group (RM-ANOVA on ranks; P ϭ 0.01), although a specific time point could not be detected (see Table 1 ). The level of FFA increased in response to epinephrine infusion (P Ͻ 0.001). Plasma FFA also increased in the control group at 5 h postinfusion (see Table 1 ). Glucose levels increased in response to epinephrine infusion (P Ͻ 0.001) and differed significantly from the control group at the cessation of infusion. After ending the infusion, glucose levels had decreased significantly at 3 and 5 h postinfusion in both groups (P Ͻ 0.001) (see Table 1 ).
DISCUSSION
This study demonstrates that epinephrine infusion increased IL-6 mRNA expression by 26-fold in human subcutaneous adipose tissue. This effect of epinephrine was short term, as the IL-6 mRNA level returned to preinfusion levels at 1.5 h postinfusion. IL-6 mRNA levels in adipose tissue also increase in response to exercise (9); however, this effect is maintained at least 3 h into the exercise recovery phase, suggesting that exercise mediates a longer term effect on IL-6 gene expression. Therefore, the short-term effect of epinephrine on IL-6 mRNA levels in adipose tissue suggests that epinephrine may relay an exercise-induced or stress-induced signal, followed by another exercise-specific substance that may be responsible for maintaining elevated IL-6 gene expression levels in adipose tissue. IL-6 plasma levels were also elevated 3.4-fold following epinephrine infusion, in accordance with previous findings (23); however, the levels are not comparable to a 3-h exercise bout, where circulating IL-6 levels normally increase ϳ10-fold. In response to exercise, muscle can account for most of the IL-6 secreted into the circulation (24) , but IL-6 is also released from adipose tissue during exercise (15) . Thus it is possible that the increase in circulating IL-6 observed during the epinephrine infusion is predominantly derived from adipose tissue.
Several studies have demonstrated that adipose tissue secretes IL-6 (5, 11), and plasma levels of IL-6 correlate with BMI, total body fat content (16, 17, 25) , and percent body fat (19) . Data on catecholamine levels in obesity have been con- Fig. 1 . IL-6-to-18S mRNA ratios in response to epinephrine infusion. Data are expressed as fold change (means Ϯ SE) from preinfusion levels. *IL-6 mRNA increased markedly in response to epinephrine infusion compared with controls, P ϭ 0.028. flicting, with high, normal, and low levels reported. However, application of sensitive techniques to assess sympathetic nervous system activity in humans provides substantial evidence that human obesity is characterized by abnormalities in sympathetic cardiovascular control with increased sympathetic nervous system activity (reviewed in Ref. 2) . Although the present study was not designed to clarify a possible relationship between chronic elevated stress and chronic low-grade inflammation, our data are compatible with such a relationship, because increased plasma epinephrine concentrations were associated with increased plasma IL-6 levels. In states of physical stress and inflammation, such as sepsis, surgery, and trauma, increased levels of systemic IL-6 are a constant finding (8, 14, 22) , and monocytes and macrophages are believed to be the source of production. The state of obesity is also associated with increased macrophage accumulation in adipose tissue, and both macrophages and adipocytes express IL-6 at a similar level (30) . Despite lean subjects being estimated to contain Ͻ10% of macrophages in adipose tissue (30) , the biopsies obtained in this study may also have contained macrophages resident within adipose tissue, and we cannot exclude the possibility that they contribute to the increase in IL-6 gene expression levels. Thus it is likely that macrophage contamination explains the high variability in the IL-6 gene expression response to epinephrine. However, as the subjects in this study were lean (BMI ϭ 24.7 kg/m 2 ), macrophages are expected to only constitute a small fraction of the adipose tissue. Moreover, previous in vitro data show that epinephrine treatment of adipocytes increases IL-6 gene expression levels and secretion to the media (18, 28) . Thus the present finding suggests that, in stress conditions with acute increases in epinephrine, adipose tissue may be an important contributor to the rise in systemic levels of Recently, our laboratory demonstrated that hyperinsulinemia is also a stimulus for IL-6 production in adipose tissue (13) . Because plasma levels of insulin decline during exercise, it is clear that insulin is not involved in the upregulation of IL-6 during exercise. Rather, insulin may be involved in the regulation of IL-6 in patients with obesity and insulin resistance. Insulin levels increased in response to epinephrine infusion, and it is possible that insulin is involved in upregulating adipose tissue IL-6 mRNA levels and plasma levels at rest.
Given that IL-6 is subject to an autocrine regulation (4) and induces adipose tissue lipolysis in vivo (26) , as well as when added directly to adipocyte cell cultures (18), we suggested that human adipose tissue would express the IL-6R. In this study, we detected IL-6R mRNA in adipose tissue; however, the expression level of the IL-6R gene was not regulated by epinephrine infusion, suggesting a lack of autocrine regulation and instead points to a targeting at the transcriptional level.
In conclusion, epinephrine infusion induces a rapid and marked increase in IL-6 mRNA in subcutaneous adipose tissue of lean healthy men with a concomitant increase in plasma IL-6. This effect is brief, as IL-6 mRNA and plasma levels return to basal levels after cessation of the epinephrine infusion.
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